Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-κB-like transcriptional regulatory motif

European Journal of Biochemistry

Volumn 263, Issue 3, 1999, Pages 765-772

  Mahony, Donna ^a   Kalionis, Bill ^b   Antalis, Toni M ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Expression screening; novH; Plasminogen activator inhibitor type 2; Serine proteinase inhibitor; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; ELECTROPHORETIC MOBILITY; EXON; GENE CONTROL; GENE INDUCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

BASE SEQUENCE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; FIBROSARCOMA; GENE EXPRESSION REGULATION; GENES, REPORTER; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NF-KAPPA B; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 0033179669     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00552.x     Document Type: Article

References (34)

1. 1. Gyetko, M.R., Shollenberger, S.B. &Sitrin, R.G. (1992) Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis faetor-a. J. Leukocyte BioL 51, 256-263.
2. 2. Kumar, S. &Baglioni, C. (1991) Protection from tumour necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chcm. 26, 20960-20964.
3. 3. Medcalf, R.L., Kruithof, E.K.O. &Schleuning, W.-D. (1988) Plasminogen activator inhibitor I and 2 are tumour necrosis factor/ cachectin-responsive genes. J. Exp. Meil. 168, 751-759.
4. 4. Vassalli, J.-D., Sappino, A.P. &Belin, D. (1991) The plasminogen activator/plasmin system. J. Clin. Invest. 88, 1067-1072.
5. 5. Belin, D., Wohlwend, A., Schleuning, W.D., Kruithof, E.K. &Vassalli, J.D. (1989) Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activator inhibitor 2. EMBO J. 8, 3287-3294.
6. 6. Dickinson, J.L., Bates, E.J., Ferrante, A. &Antalis, T.M. (1995) Plasminogen activator inhibitor type 2 inhibits tumour necrosis factor a-induced apoptosis. J. Biol. Client. 270, I -11.
7. 7. Antalis, T.M., Linn, M.L., Donnan, K., Maleo, L., Gardiner, J., Dickinson, J.L., Buttigieg, K. &Suhrhier, A. (1998) The serine proteinase inhibitor (serpin) plasminogen activator inhibitor type 2 protects against viral cytopathic effects by constitutive interferon ct/ß priming, y. Exp. Mcd. 187, 1799-1811.
8. 8. Dougherty, K.M., Pearson, J.M., Yang, A.Y., Westrick, R.J., Baker, M.S. &Ginsburg, D. (1999) The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. P me. Nat! Acad. Sei. USA 96, 686-691.
9. 9. Kruithof, E.K.O., Baker, M.S. &Bunn, C.L. (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86, 4007-4024.
10. 10. Antalis, T.M., Costelloe, E., Muddiman, J., Ogbourne, S. &Donnan, K. (1996) Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: localisation of an upstream transcriptional silencer. Blood 88, 3686-3697.
11. 11. Medcalf, R.L. (1992) Cell-and gene-specific interactions between signal transduction pathways revealed by okadaic acid. J. Rio/. Client. 267, 12220-12226.
12. 12. Antalis, T.M. &Dickinson, J.L. (1992) Control of plasminogen-activator inhibitor type 2 gene expression in ihe differentiation of monocytic cells. Ear. J. Bioehem. 205, 203-209.
13. 13. Cousin, E., Medcalf, R.L., Bergonzelli, O.E. &Kruithof, E.K.O. (1991) Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res. 19, 3881-3886.
14. 14. Antalis, T.M., Godbolt, D. &Stringer, B.W. (1993) Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2, Gene 134, 201-208.
15. 15. Dear, A.E. &Medcalf, R.L. (1995) The cellular and molecular biology of plasminogen activator inhibitor type 2. Fihrinnly.ii.i 9, 321-330.
16. 16. Schuster, W.A., Medcalf, R.L. &Kruithof, E.K.O. (1994) Localization and characterization of a retinoic acid response-like element in the plasminogen activator inhibitor-2 gene promoter. Fibrinolysis 8, 113-119.
17. 17. Mahony, D., Stringer, B.W., Dickinson, J.L. &Antalis, T.M. (1998) DNase T hypersensitivity sites in the 5' flanking region of the human plasminogen activator inhibitor type 2 (PAI-2) gene are associated with basal and tumor necrosis factor-alpha-induced transcription in monocytes. Eur. J. Bioehem. 256, 550-559.
18. 18. Dear, A.E., Shen, Y, Ruegg, M. &Medcalf, R.L. (1996) Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type 2 gene expression. Eur. J. Bioehem. 241, 93-100.
19. 19. Baeuerle, P.A. &Henkel, T. (1994) Function and activation of NE-KB in the immune system. Anna. Kev. Immimol. 12, 141-179.
20. 20. Grimm, S. &Baeuerle, P.A. (1993) The inducible transcription factor NF-KB: structure-function relationship of its protein subunits. Bioehem. J. 290, 297-308.
21. 21. Shakhov, A.N., Collar!, M.A., Vassalli, P., Nedospasov, S.A. & Jongeneel, C.V. (1990) KB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor a gene in primary macrophages. J. E\p. Med. 171, 35-47.
22. 22. Rattner, A., Korner, M., Walker, M.D. &Citri, Y. (1993) NF-KB activates the HIV promoter in neurons. EMBO J. 12, 4261-4267.
23. 23. Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, J., Bensi, G. &Fenton, M. (1993) Characterization of a functional NE-xB site in the human interleukin Iß promoter: evidence for a positive auloregulatory loop. Mol. Cell. Biol. 13,6231-6240.
24. 24. Ye, R.D., Ahern, S.M., Le Beau, M.M., Lebo, R.V. &Sadler, J.E. (1989) Structure of the gene for human plasminogen activator inhibitor-2. / Biol. Cliem. 264, 5495-5502.
25. 25. Horion, R.M., Hunt, H.D., Ho, S.N., Pullen, J.K. &Pease, L.R. (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77, 61-68.
26. 26. Henkel, T., Machleidt, T., Alkalay, L, Kranke, M., Ben-Neriah, Y. &Baeucrle, P.A. (1993) Rapid proteolysis of iKB-a is necessary for activation of transcription factor NF-KB. Naiure 36, 182-185.
27. 27. Oshorn, L., Kunkel, S. &Nabel, G.J. (1989) Tumor necrosis factor a and interleukin 1 stimulate the human immunodefiency virus enhancer by activation of the nuclear factor Kb. Proc. Null Acad. Sei. USA 86, 2336-2340.
28. 28. Baeucrk, P.A. &Baltimore, D. (1988) IxB: a specific inhibitor of the NF-KB transcription factor. Science1 242, 540-546.
29. 29. Kuliunis, B. &O'Farrell, PH. (1993) A universal target sequence is bound in vitro by diverse homeodomains. Mech. Dev. 43, 57-70.
30. 30. Kuliunis, B. (1995) Gene isolation by screening gtl1 expression libraries with DNA binding site probes. Methods Mol. Biol. 37, 393-407.
31. 31. Altschul, S.F., Gish, W., Miller, W., Myers, E.W. &Lipman, D.J. (1990) Basic local alignment search tool. / Mol. Binl. 215, 403-410.
32. 32. Martinerie, C., Huff, V., Joubert, I., Badzioch, M., Saunders, G., Strong, L. &Perbal, B. (1994) Structural analysis of the human nov proto-oncogene and expression in Wilms tumors. Onfogene 9, 2729-2732.
33. 33. Joliot, V, Martinerie, C., Dambrine, G., Plassiart, G., Brisac, M., Crochet, J. &Perbal, B. (1992) Proviral rearrangements and overexpression of a new cellular gene (nov) in mycloblastosis-associated virus type 1-induced nephroblastomas. Mol. Cell. Bin!. 12, 10-21.
34. 34. Bork, P. (1993) The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327, 125-130.